Itemized clinician ratings versus global ratings of symptom severity in patients with schizophrenia

Kathy Shores-Wilson, Melanie M. Biggs, Alexander L. Miller, Thomas J. Carmody, John A. Chiles, A. John Rush, M. Lynn Crismon, Marcia G. Toprac, Bradley P. Witte, Joe C. Webster

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This study compares ratings obtained with an itemized clinician-rated symptom severity measure - the 24-item Brief Psychiatric Rating Scale (BPRS24) - with a Physician Global Rating Scale (PhGRS) and a Patient Global Rating Scale (PtGRS) in assessing treatment outcomes in patients with schizophrenia (SCZ). A total of 91 patients (31 inpatients and 60 outpatients) with SCZ were enrolled in a feasibility study of the use of medication algorithms in the treatment of SCZ. Clinicians completed the BPRS24 and the PhGRS; patients completed the PtGRS at each visit. The analyses reported here were conducted using the original BPRS18 and four items from the BPRS18 that rate the positive symptoms of psychosis (the Positive Symptom Rating Scale or PSRS), comparing anchored with global rating scales and with one another. The PtGRS had the lowest effect size (0.8) and was negatively correlated with the other ratings in inpatients. The PhGRS was significantly correlated (0.46) with the BPRS18, but the same person completed both ratings. The effect size of the PhGRS (0.6) was generally lower than with the BPRS18 (1.4) in differentiating responders from non-responders. On average, the PSRS had a slightly lower effect size than the longer itemized BPRS18, but the results support its use as a quantitative rating in circumstances where it is not feasible to routinely use a lengthier scale.

Original languageEnglish (US)
Pages (from-to)45-53
Number of pages9
JournalInternational Journal of Methods in Psychiatric Research
Volume11
Issue number1
StatePublished - 2002

Fingerprint

Schizophrenia
Physicians
Inpatients
Brief Psychiatric Rating Scale
Feasibility Studies
Psychotic Disorders
Outpatients
Therapeutics

Keywords

  • Global measures
  • Schizophrenia
  • Symptom severity

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Itemized clinician ratings versus global ratings of symptom severity in patients with schizophrenia. / Shores-Wilson, Kathy; Biggs, Melanie M.; Miller, Alexander L.; Carmody, Thomas J.; Chiles, John A.; Rush, A. John; Crismon, M. Lynn; Toprac, Marcia G.; Witte, Bradley P.; Webster, Joe C.

In: International Journal of Methods in Psychiatric Research, Vol. 11, No. 1, 2002, p. 45-53.

Research output: Contribution to journalArticle

Shores-Wilson, Kathy ; Biggs, Melanie M. ; Miller, Alexander L. ; Carmody, Thomas J. ; Chiles, John A. ; Rush, A. John ; Crismon, M. Lynn ; Toprac, Marcia G. ; Witte, Bradley P. ; Webster, Joe C. / Itemized clinician ratings versus global ratings of symptom severity in patients with schizophrenia. In: International Journal of Methods in Psychiatric Research. 2002 ; Vol. 11, No. 1. pp. 45-53.
@article{340ca37266fc43dba7cda64812a672a1,
title = "Itemized clinician ratings versus global ratings of symptom severity in patients with schizophrenia",
abstract = "This study compares ratings obtained with an itemized clinician-rated symptom severity measure - the 24-item Brief Psychiatric Rating Scale (BPRS24) - with a Physician Global Rating Scale (PhGRS) and a Patient Global Rating Scale (PtGRS) in assessing treatment outcomes in patients with schizophrenia (SCZ). A total of 91 patients (31 inpatients and 60 outpatients) with SCZ were enrolled in a feasibility study of the use of medication algorithms in the treatment of SCZ. Clinicians completed the BPRS24 and the PhGRS; patients completed the PtGRS at each visit. The analyses reported here were conducted using the original BPRS18 and four items from the BPRS18 that rate the positive symptoms of psychosis (the Positive Symptom Rating Scale or PSRS), comparing anchored with global rating scales and with one another. The PtGRS had the lowest effect size (0.8) and was negatively correlated with the other ratings in inpatients. The PhGRS was significantly correlated (0.46) with the BPRS18, but the same person completed both ratings. The effect size of the PhGRS (0.6) was generally lower than with the BPRS18 (1.4) in differentiating responders from non-responders. On average, the PSRS had a slightly lower effect size than the longer itemized BPRS18, but the results support its use as a quantitative rating in circumstances where it is not feasible to routinely use a lengthier scale.",
keywords = "Global measures, Schizophrenia, Symptom severity",
author = "Kathy Shores-Wilson and Biggs, {Melanie M.} and Miller, {Alexander L.} and Carmody, {Thomas J.} and Chiles, {John A.} and Rush, {A. John} and Crismon, {M. Lynn} and Toprac, {Marcia G.} and Witte, {Bradley P.} and Webster, {Joe C.}",
year = "2002",
language = "English (US)",
volume = "11",
pages = "45--53",
journal = "International Journal of Methods in Psychiatric Research",
issn = "1049-8931",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Itemized clinician ratings versus global ratings of symptom severity in patients with schizophrenia

AU - Shores-Wilson, Kathy

AU - Biggs, Melanie M.

AU - Miller, Alexander L.

AU - Carmody, Thomas J.

AU - Chiles, John A.

AU - Rush, A. John

AU - Crismon, M. Lynn

AU - Toprac, Marcia G.

AU - Witte, Bradley P.

AU - Webster, Joe C.

PY - 2002

Y1 - 2002

N2 - This study compares ratings obtained with an itemized clinician-rated symptom severity measure - the 24-item Brief Psychiatric Rating Scale (BPRS24) - with a Physician Global Rating Scale (PhGRS) and a Patient Global Rating Scale (PtGRS) in assessing treatment outcomes in patients with schizophrenia (SCZ). A total of 91 patients (31 inpatients and 60 outpatients) with SCZ were enrolled in a feasibility study of the use of medication algorithms in the treatment of SCZ. Clinicians completed the BPRS24 and the PhGRS; patients completed the PtGRS at each visit. The analyses reported here were conducted using the original BPRS18 and four items from the BPRS18 that rate the positive symptoms of psychosis (the Positive Symptom Rating Scale or PSRS), comparing anchored with global rating scales and with one another. The PtGRS had the lowest effect size (0.8) and was negatively correlated with the other ratings in inpatients. The PhGRS was significantly correlated (0.46) with the BPRS18, but the same person completed both ratings. The effect size of the PhGRS (0.6) was generally lower than with the BPRS18 (1.4) in differentiating responders from non-responders. On average, the PSRS had a slightly lower effect size than the longer itemized BPRS18, but the results support its use as a quantitative rating in circumstances where it is not feasible to routinely use a lengthier scale.

AB - This study compares ratings obtained with an itemized clinician-rated symptom severity measure - the 24-item Brief Psychiatric Rating Scale (BPRS24) - with a Physician Global Rating Scale (PhGRS) and a Patient Global Rating Scale (PtGRS) in assessing treatment outcomes in patients with schizophrenia (SCZ). A total of 91 patients (31 inpatients and 60 outpatients) with SCZ were enrolled in a feasibility study of the use of medication algorithms in the treatment of SCZ. Clinicians completed the BPRS24 and the PhGRS; patients completed the PtGRS at each visit. The analyses reported here were conducted using the original BPRS18 and four items from the BPRS18 that rate the positive symptoms of psychosis (the Positive Symptom Rating Scale or PSRS), comparing anchored with global rating scales and with one another. The PtGRS had the lowest effect size (0.8) and was negatively correlated with the other ratings in inpatients. The PhGRS was significantly correlated (0.46) with the BPRS18, but the same person completed both ratings. The effect size of the PhGRS (0.6) was generally lower than with the BPRS18 (1.4) in differentiating responders from non-responders. On average, the PSRS had a slightly lower effect size than the longer itemized BPRS18, but the results support its use as a quantitative rating in circumstances where it is not feasible to routinely use a lengthier scale.

KW - Global measures

KW - Schizophrenia

KW - Symptom severity

UR - http://www.scopus.com/inward/record.url?scp=0035992446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035992446&partnerID=8YFLogxK

M3 - Article

C2 - 12459804

AN - SCOPUS:0035992446

VL - 11

SP - 45

EP - 53

JO - International Journal of Methods in Psychiatric Research

JF - International Journal of Methods in Psychiatric Research

SN - 1049-8931

IS - 1

ER -